3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
294
Other hematologic neoplasm
182
Dermatologic
98
Plasma cell
92
Myeloid
76
Sarcoma
33
Breast
22
Genitourinary
21
Thoracic
18
Gynecologic
16
Gastrointestinal
16
CNS
15
Classical hematology
14
Head & Neck
12
Other neoplasm
10
Other solid neoplasm
1
Other
1
Endocrine
1
Conditions
Mucositis
7
Obesity
6
Polycystic Ovary Syndrome
3
Stomatitis
2
Head and Neck Neoplasms
2
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Lipid Metabolism Disorders
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hirsutism
1
Endometrial Neoplasms
1
Dyspnea
1
Drug-Related Side Effects and Adverse Reactions
1
Disease
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Interventions
angiotensin I (1-7)
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Hodgkin Disease
×
Other
×
Clear all
NCT01300611
2020-12-08
USBTXA127CBT
Tarix Pharmaceuticals
Phase 1
Terminated
20 enrolled